Details for Patent: 11,554,229
✉ Email this page to a colleague
Which drugs does patent 11,554,229 protect, and when does it expire?
Patent 11,554,229 protects XHANCE and is included in one NDA.
This patent has forty-one patent family members in seventeen countries.
Drugs Protected by US Patent 11,554,229
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,554,229
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014242658 | ⤷ Try a Trial | |||
Australia | 2015279154 | ⤷ Try a Trial | |||
Australia | 2019200191 | ⤷ Try a Trial | |||
Australia | 2020202029 | ⤷ Try a Trial | |||
Australia | 2021215246 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |